German biotech company BioNTech and US pharmaceutical Pfizer announced on Monday promising early results from their phase 3 clinical trial for a vaccine against SARS-CoV-2, the virus that causes COVID-19.
Nov 10, 2020
0
3
Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons ...
Nov 5, 2020
1
451
Differences in biological sex can dictate lifelong disease patterns, says a new study by Michigan State University researchers that links connections between specific hormones present before and after birth with immune response ...
Sep 15, 2020
0
353
A new study of the antibodies produced by people with gluten sensitivity may lead to a better way to detect the condition and treat it.
Sep 1, 2020
0
453
Do you dream of ice cream in a Zoom meeting or reach for potato chips as you check the latest COVID-19 stats? You may be experiencing something deeper than a whim, according to a team of scientists at the Human Nutrition ...
Aug 3, 2020
0
14
As genetic sequences of SARS-CoV-2, the cause of the novel pneumonia (COVID-19), are similar to those of the 2003 SARS virus, SARS-CoV, knowledge and data of SARS-CoV may be useful for finding ways to combat COVID-19. Such ...
Jun 30, 2020
0
2
When it comes to surviving critical cases of COVID-19, it appears that men draw the short straw.
Jun 9, 2020
0
2
The lens of the eye is an unusual organ. Unlike most of the body's organs, blood vessels don't reach the lens. If they did, they'd obscure our vision and we wouldn't be able to see. The lack of vasculature led scientists ...
May 26, 2020
0
157
Efforts to design a safe vaccine for COVID-19 are moving forward at full throttle, yet experts agree that it's likely to be a year, at least, before an immunisation is ready. Meanwhile, scientists around Europe are exploring ...
May 26, 2020
0
12
A team of researchers at the University of California has been studying proteins that the SARS-CoV-2 virus uses to bind to proteins in the lungs, and has identified multiple drug candidates that might be useful to treat patients ...
